UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its stake in shares of Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 584.6% during the 1st quarter, according to its most recent filing with the SEC. The firm owned 9,218,848 shares of the real estate investment trust's stock after purchasing an additional 7,872,150 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC owned approximately 1.33% of Healthpeak Properties worth $186,405,000 at the end of the most recent quarter.
Several other hedge funds have also modified their holdings of DOC. Machina Capital S.A.S. grew its position in shares of Healthpeak Properties by 62.8% during the 1st quarter. Machina Capital S.A.S. now owns 37,160 shares of the real estate investment trust's stock valued at $751,000 after acquiring an additional 14,336 shares during the period. Douglas Lane & Associates LLC grew its position in shares of Healthpeak Properties by 8.5% during the 1st quarter. Douglas Lane & Associates LLC now owns 2,792,850 shares of the real estate investment trust's stock valued at $56,471,000 after acquiring an additional 218,395 shares during the period. Cambridge Investment Research Advisors Inc. grew its position in shares of Healthpeak Properties by 6.9% during the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 357,520 shares of the real estate investment trust's stock valued at $7,229,000 after acquiring an additional 23,135 shares during the period. Ibex Wealth Advisors acquired a new stake in shares of Healthpeak Properties during the 1st quarter valued at about $5,056,000. Finally, Vert Asset Management LLC grew its position in shares of Healthpeak Properties by 6.9% during the 1st quarter. Vert Asset Management LLC now owns 325,143 shares of the real estate investment trust's stock valued at $6,574,000 after acquiring an additional 20,924 shares during the period. 93.57% of the stock is owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
A number of research firms have recently commented on DOC. Raymond James Financial upgraded Healthpeak Properties from a "market perform" rating to an "outperform" rating and set a $20.00 target price on the stock in a research report on Monday. Morgan Stanley lowered their price objective on Healthpeak Properties from $22.00 to $21.00 and set an "overweight" rating on the stock in a report on Friday, August 22nd. Scotiabank cut Healthpeak Properties from a "sector outperform" rating to a "sector perform" rating and lowered their price objective for the stock from $21.00 to $19.00 in a report on Tuesday, July 29th. Wall Street Zen cut Healthpeak Properties from a "hold" rating to a "sell" rating in a report on Monday, July 7th. Finally, Evercore ISI set a $22.00 price objective on Healthpeak Properties in a report on Monday. Eight research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company's stock. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average target price of $21.45.
Get Our Latest Report on DOC
Healthpeak Properties Price Performance
Shares of Healthpeak Properties stock traded up $0.22 on Wednesday, hitting $18.45. 1,091,873 shares of the company were exchanged, compared to its average volume of 6,059,492. The stock has a market capitalization of $12.82 billion, a price-to-earnings ratio of 76.86, a price-to-earnings-growth ratio of 2.35 and a beta of 1.07. The company has a 50-day moving average price of $17.76 and a 200 day moving average price of $18.15. Healthpeak Properties, Inc. has a 1-year low of $16.63 and a 1-year high of $23.26. The company has a quick ratio of 1.28, a current ratio of 1.28 and a debt-to-equity ratio of 1.06.
Healthpeak Properties (NYSE:DOC - Get Free Report) last issued its earnings results on Thursday, July 24th. The real estate investment trust reported $0.46 earnings per share for the quarter, hitting the consensus estimate of $0.46. The business had revenue of $694.35 million for the quarter, compared to analysts' expectations of $697.14 million. Healthpeak Properties had a return on equity of 1.85% and a net margin of 5.90%.The business's revenue for the quarter was down .2% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.45 EPS. Healthpeak Properties has set its FY 2025 guidance at 1.810-1.870 EPS. As a group, sell-side analysts predict that Healthpeak Properties, Inc. will post 1.86 earnings per share for the current fiscal year.
Healthpeak Properties Dividend Announcement
The company also recently declared a monthly dividend, which was paid on Friday, August 29th. Stockholders of record on Monday, August 18th were given a dividend of $0.1017 per share. This represents a c) annualized dividend and a dividend yield of 6.6%. The ex-dividend date of this dividend was Monday, August 18th. Healthpeak Properties's payout ratio is presently 508.33%.
Insider Activity at Healthpeak Properties
In other news, CEO Scott M. Brinker purchased 1,490 shares of Healthpeak Properties stock in a transaction dated Monday, August 4th. The shares were purchased at an average price of $16.83 per share, with a total value of $25,076.70. Following the transaction, the chief executive officer owned 211,906 shares in the company, valued at $3,566,377.98. This represents a 0.71% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Over the last 90 days, insiders have purchased 8,783 shares of company stock worth $150,129. 0.23% of the stock is currently owned by insiders.
Healthpeak Properties Profile
(
Free Report)
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Featured Stories

Before you consider Healthpeak Properties, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthpeak Properties wasn't on the list.
While Healthpeak Properties currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.